tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ESPR Stock Latest News

Esperion Delays Q2 2025 Financial Report Filing
Company AnnouncementsEsperion Delays Q2 2025 Financial Report Filing
12d ago
ESPR
Esperion Therapeutics Reports Strong Q2 2025 Growth
PremiumCompany Announcements
Esperion Therapeutics Reports Strong Q2 2025 Growth
18d ago
ESPR
Esperion Therapeutics’ Earnings Call Highlights Growth
PremiumCompany Announcements
Esperion Therapeutics’ Earnings Call Highlights Growth
18d ago
ESPR
Esperion’s Strong Financial Performance and Strategic Initiatives Drive Buy Rating
PremiumRatings
Esperion’s Strong Financial Performance and Strategic Initiatives Drive Buy Rating
18d ago
ESPR
Esperion reports Q2 EPS 2c, consensus (16c)
PremiumThe Fly
Esperion reports Q2 EPS 2c, consensus (16c)
19d ago
ESPR
Esperion expects to achieve sustainable profitability in Q1 2026
PremiumThe FlyEsperion expects to achieve sustainable profitability in Q1 2026
19d ago
ESPR
Esperion Therapeutics (ESPR) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Esperion Therapeutics (ESPR) Q2 Earnings Cheat Sheet
21d ago
ESPR
Esperion up 25c to $1.59
Premium
The Fly
Esperion up 25c to $1.59
1M ago
ESPR
Esperion signs settlement with Accord Healthcare over Nexletol generic version
PremiumThe Fly
Esperion signs settlement with Accord Healthcare over Nexletol generic version
2M ago
ESPR
Esperion Expands Board with New Appointment
PremiumCompany Announcements
Esperion Expands Board with New Appointment
2M ago
8K
ESPR
Esperion appoints Craig Thompson to board of directors
PremiumThe Fly
Esperion appoints Craig Thompson to board of directors
2M ago
ESPR
Esperion’s Strategic Growth and Global Expansion Drive Buy Rating
PremiumRatings
Esperion’s Strategic Growth and Global Expansion Drive Buy Rating
2M ago
ESPR
Esperion participates in a conference call with Cantor Fitzgerald
PremiumThe FlyEsperion participates in a conference call with Cantor Fitzgerald
2M ago
ESPR
Esperion’s Strategic Positioning and Growth Potential: Legal Settlements and Market Expansion Drive Buy Rating
Premium
Ratings
Esperion’s Strategic Positioning and Growth Potential: Legal Settlements and Market Expansion Drive Buy Rating
3M ago
ESPR
Esperion Gains Strong Shareholder Support at Annual Meeting
Premium
Company Announcements
Esperion Gains Strong Shareholder Support at Annual Meeting
3M ago
8K
ESPR
Esperion reaches settlement agreement with Hetero USA, affiliates
PremiumThe Fly
Esperion reaches settlement agreement with Hetero USA, affiliates
3M ago
ESPR
Esperion reaches settlement agreement with Micro Labs
PremiumThe Fly
Esperion reaches settlement agreement with Micro Labs
3M ago
ESPR
Esperion’s Strategic Expansion and Promising Financial Outlook Earns Buy Rating
PremiumRatings
Esperion’s Strategic Expansion and Promising Financial Outlook Earns Buy Rating
4M ago
ESPR
Esperion enters license and distribution agreement with HLS Therapeutics
PremiumThe Fly
Esperion enters license and distribution agreement with HLS Therapeutics
4M ago
ESPR
Esperion Therapeutics Reports Mixed Q1 2025 Results
PremiumCompany AnnouncementsEsperion Therapeutics Reports Mixed Q1 2025 Results
4M ago
ESPR
Esperion Therapeutics Reports Strong Q1 2025 Earnings
Premium
Company Announcements
Esperion Therapeutics Reports Strong Q1 2025 Earnings
4M ago
ESPR
Esperion’s Growth Potential: Buy Rating Affirmed Amid Strong Sales and Strategic Advances
Premium
Ratings
Esperion’s Growth Potential: Buy Rating Affirmed Amid Strong Sales and Strategic Advances
4M ago
ESPR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >